News About: Pharm. Industry
Strengthening competitiveness by strategic tie-up
So far a doc business cooperation between a domestic and foreign invested company has been proceeded mainly in aiming to reciprocate and share complementarily their products and sales powers. By taking an oppo...
Pharm. Firms hold shareholder's meeting
OVERVIEW.
13 leading pharmaceutical firms listed in the public stock exchange board including Dong-A, Green-Cross and Yuhan held shareholder's meetings. on Mar. 13th.
In the shareholder's meetings, mo...
Sales to retail pharmacy declined
A chronic pharmaceutical recession ensued on remarkable changes in pharmaceutical distribution structures. Since the second half of 1997 the retail pharmacy business backslid and therefore the direct sales deal ...
Strategic tie-up between yuhan and Dong-A
3-year's 10 billion Won investment for development of an anti-osteoporosis drug.
Two leading pharmaceutical companies, Yuhan (Representative: Kim Sun-jin) and Dong-A (Representative: Yu Choong-shik) ag...
Management target focused by major pharm.
The leading company executives put the profitability and cash procurement with the most priority on their management target under the IMF financial crisis, it was found in our recent interviews.
To acco...
Fair margins pre-requisite to pharmaceutical industrial progress.
President Kim Jeong-soo and Chairman Lee Jang-han (Chongkundang) of the KPMA accepted a courtesy call of Dr. Harvey E. Bale Jr, the Secretary General of the IFPMA, at 11 a.m. on Nov. 13 and shared the opinion of which...
